Teknoinvest

Teknoinvest is a prominent Norwegian venture capital firm that specializes in early-stage and growth-stage investments within the life sciences and information technology sectors. Established in 1984, it is one of the oldest venture capital firms in Norway and has played a significant role in developing the Nordic biotechnology ecosystem. The firm invests in companies across Scandinavia and North America, focusing on innovative therapeutics, medical technologies, and diagnostics. Teknoinvest is known for its hands-on investment approach, providing strategic guidance and leveraging its extensive network to support portfolio companies through clinical development and exit. Notable past investments include Algeta, which was acquired by Bayer for $2.9 billion, as well as Photocure and Clavis Pharma.